Pressmeddelanden

REG
Coegin Pharma AB (publ) publishes its quarterly report for the third quarter of 2025 Summary of interim reportThe third quarter of 2025 marks a historic turning point for Coegin Pharma. The company has successfully transitioned from a development-focused biotech...
First Follicopeptide® powered product available for consumer pre-orders November 16 - a historic milestone for Coegin Pharma Coegin Pharma AB ("Coegin" or "the Company") is proud to announce that starting November 16, customers can pre-order Gents Power Hair Activating Formula through Gents' online sto...
Coegin introduces new tailor-made Follicopeptide complementary product - launching early 2026 Coegin Pharma AB ("Coegin" or "the Company") announces that it has finalized the development of a new, tailor-made Follicopeptide complementary product. It is designed to strengt...
REG MAR
Coegin Pharma enters collaboration with Hårklinikken - expands Follicopeptide® commercialization with a world renowned hair clinic brand Coegin Pharma AB ("Coegin" or "the Company") has entered a collaboration with Hårklinikken, a global actor in premium, science-driven hair and scalp health, through the signing o...
Coegin Pharma establishes own agile production facility in Denmark - ensuring control, scalability, and cost efficiency for next phase of growth Coegin Pharma AB ("Coegin" or "the Company") provides a status update about the establishment of its own agile production facility in Denmark. It enables the Company to secure fu...
REG MAR
Coegin Pharma enters collaboration with Polish distributor Mercapharm - expands Follicopeptide® commercialisation to Poland Coegin Pharma AB ("Coegin" or "the Company") has entered a distribution agreement with Mercapharm, a fast-growing Polish distributor, through the signing of a limited purchase or...
Visa fler pressmeddelanden

Rapporter

Datum Rubrik
Interim Report Q3 2025
Quarterly report Q2
Delårsrapport Q1 2025

Video

Finansiell kalender

Bokslutskommuniké 2025 Bokslutskommuniké

Om Coegin Pharma

Coegin Pharma är ett svenskt bioteknikföretag som utvecklar banbrytande innovationer för hår och hud.

Webbplats
www.coeginpharma.com
Bransch
Bioteknik

Prenumerera

Få löpande information från Coegin Pharma via e-post.

Språk
Nyhetstyper

Handelsinformation

Kurs 5,34 SEK (2025-11-25)
Förändring 35,88% (2024-11-25)
Marknad NGM Nordic SME Kortnamn COEGIN ISIN-kod SE0020357754

IR-Kontakt

Jens Eriksson vd [email protected]